Research and Markets has announced the addition of the "HIV Pipeline Highlights - 2017" drug pipelines to their offering.

HIV Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global HIV market. It covers emerging therapies for HIV in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides HIV pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides HIV pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides HIV pipeline products by the company.

Short-term Launch Highlights:

Find out which HIV pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. HIV Pipeline by Stages

2. HIV Pipeline by Drug Class

3. HIV Pipeline by Company

4. HIV Phase 3 Clinical Trial Insights

5. HIV Phase 2 Clinical Trial Insights

6. HIV Phase 1 Clinical Trial Insights

7. HIV Preclinical Research Insights

8. HIV Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/c3f4nw/hiv_pipeline